ArticleScientific reports2025

125I inhibits the progression of cervical cancer by upregulating the HSF1/PU.1/SYK signaling pathway and consequently enhancing the apoptotic response mediated by ROS/USP7/P53.

Xiaomei Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.